Sfoglia per Autore
Rituximab treatment in patients with active Graves' orbitopathy : effects on proinflammatory and humoral immune reactions
2010 G.M. Vannucchi, I. Campi, M. Bonomi, D. Covelli, D. Dazzi, N. Currò, S. Simonetta, P. Bonara, L. Persani, C. Guastella, J. Wall, P.L.M. Beck Peccoz, M. Salvi
Small dose of rituximab for graves orbitopathy : new insights into the mechanism of action
2012 M. Salvi, G. Vannucchi, N. Currò, M. Introna, S. Rossi, P. Bonara, D. Covelli, D. Dazzi, C. Guastella, L. Pignataro, R. Ratiglia, J. Golay, P. Beck-Peccoz
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy
2012 G. Vannucchi, D. Covelli, N. Currò, D. Dazzi, A. Maffini, I. Campi, P. Bonara, C. Guastella, L. Pignataro, R. Ratiglia, P. Beck Peccoz, M. Salvi
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.
2013 I. Campi, G. Vannucchi, A. Minetti, D. Dazzi, S. Avignone, D. Covelli, N. Currò, R. Ratiglia, C. Guastella, L. Pignataro, P. Beck-Peccoz, M. Salvi
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy
2014 N. Curro, D. Covelli, G. Vannucchi, I. Campi, G. Pirola, S. Simonetta, D. Dazzi, C. Guastella, L. Pignataro, P. Beck-Peccoz, R. Ratiglia, M. Salvi
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves' orbitopathy : a randomized controlled study
2015 M. Salvi, G. Vannucchi, N. Currò, I. Campi, D. Covelli, D. Dazzi, S. Simonetta, C. Guastella, L. Pignataro, S. Avignone, P. Beck-Peccoz
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy
2015 D. Covelli, G. Vannucchi, I. Campi, N. Currò, R. D'Ambrosio, M. Maggioni, U. Gianelli, P. Beck-Peccoz, M. Salvi
Thyroid volume and serum calcitonin changes during pregnancy
2017 G. Vannucchi, D. Covelli, B. Vigo, M. Perrino, L. Mondina, L. Fugazzola
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy
2018 L. Zhang, G. Masetti, G. Colucci, M. Salvi, D. Covelli, A. Eckstein, U. Kaiser, M.S. Draman, I. Muller, M. Ludgate, L. Lucini, F. Biscarini
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study
2019 G. Vannucchi, D. Covelli, I. Campi, N. Curro, D. Dazzi, M. Rodari, G. Pepe, A. Chiti, C. Guastella, E. Lazzaroni, M. Salvi
Asymmetry indicates more severe and active disease in Graves’ orbitopathy : results from a prospective cross-sectional multicentre study
2020 P. Perros, M.P. Zarkovic, G.C. Panagiotou, C. Azzolini, G. Ayvaz, L. Baldeschi, L. Bartalena, A.M. Boschi, M. Nardi, T.H. Brix, D. Covelli, C. Daumerie, A.K. Eckstein, N. Fichter, S. Ciric, L. Hegedus, G.J. Kahaly, O. Konuk, J.J. Lareida, O.E. Okosieme, M. Leo, L. Mathiopoulou, L. Clarke, F. Menconi, D.S. Morris, J. Orgiazzi, S. Pitz, M. Salvi, I. Muller, M. Knezevic, W.M. Wiersinga, N. Curro, C.M. Dayan, C. Marcocci, M. Marino, L. Moller, S.H. Pearce, F. Toruner, M. Bernard, P. Perros, J.J. Lareida
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience
2020 I. Campi, D. Covelli, C. Moran, L. Fugazzola, C. Cacciatore, F. Orlandi, G. Gallone, K. Chatterjee, P. Beck-Peccoz, L. Persani
SARS-CoV-2-related atypical thyroiditis
2020 I. Muller, D. Cannavaro, D. Dazzi, D. Covelli, G. Mantovani, A. Muscatello, E. Ferrante, E. Orsi, V. Resi, V. Longari, M. Cuzzocrea, A. Bandera, E. Lazzaroni, A. Dolci, F. Ceriotti, T.E. Re, A. Gori, M. Arosio, M. Salvi
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy
2021 G.M. Vannucchi, I. Campi, D. Covelli, N. Curro, E. Lazzaroni, A. Palomba, D. Soranna, A. Zambon, L. Fugazzola, I. Muller, C. Guastella, M. Salvi
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
2022 I. Campi, G. Vannucchi, I. Muller, E. Lazzaroni, N. Currò, M. Dainese, B. Montacchini, D. Covelli, C. Guastella, L. Pignataro, L. Fugazzola, M. Arosio, M. Salvi
Gut microbiome associated with Graves' disease and Graves' orbitopathy: the INDIGO* multi-centre European study
2023 F. Biscarini, G. Masetti, I. Muller, H.L. Verhasselt, D. Covelli, G. Colucci, L. Zhang, M.S. Draman, O. Okosieme, P. Taylor, C. Daumerie, M. Burlacu, M. Marinò, D.G. Ezra, P. Perros, S. Plummer, A. Eckstein, M. Salvi, J.R. Marchesi, M. Ludgate
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile